312 related articles for article (PubMed ID: 16831075)
1. Positron emission tomography in gynecological malignancies.
Kumar R; Chauhan A; Jana S; Dadparvar S
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1033-44. PubMed ID: 16831075
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging for gynecologic malignancy.
Lai CH; Yen TC; Chang TC
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):37-41. PubMed ID: 17218850
[TBL] [Abstract][Full Text] [Related]
3. The role of
Narayanan P; Sahdev A
Br J Radiol; 2017 Nov; 90(1079):20170283. PubMed ID: 28830238
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.
Sakurai H; Suzuki Y; Nonaka T; Ishikawa H; Shioya M; Kiyohara H; Katoh H; Nakayama Y; Hasegawa M; Nakano T
Gynecol Oncol; 2006 Mar; 100(3):601-7. PubMed ID: 16257440
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Chung HH; Kim SK; Kim TH; Lee S; Kang KW; Kim JY; Park SY
Gynecol Oncol; 2006 Oct; 103(1):165-70. PubMed ID: 16574205
[TBL] [Abstract][Full Text] [Related]
6. Gynecological cancers.
Avril N; Gourtsoyianni S; Reznek R
Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
[TBL] [Abstract][Full Text] [Related]
7. Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.
Nogami Y; Iida M; Banno K; Kisu I; Adachi M; Nakamura K; Umene K; Masuda K; Tominaga E; Tanaka K; Aoki D
Anticancer Res; 2014 Feb; 34(2):585-92. PubMed ID: 24510987
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Assessment of Gynecologic Malignancies.
Tripathy S; Parida GK; Kumar R
PET Clin; 2018 Apr; 13(2):269-288. PubMed ID: 29482754
[No Abstract] [Full Text] [Related]
9. FDG-PET for management of cervical and ovarian cancer.
Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
[TBL] [Abstract][Full Text] [Related]
10. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
[TBL] [Abstract][Full Text] [Related]
11. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
Yen TC; Ng KK; Ma SY; Chou HH; Tsai CS; Hsueh S; Chang TC; Hong JH; See LC; Lin WJ; Chen JT; Huang KG; Lui KW; Lai CH
J Clin Oncol; 2003 Oct; 21(19):3651-8. PubMed ID: 14512397
[TBL] [Abstract][Full Text] [Related]
12. PET imaging in gynecologic malignancies.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1155-67, ix. PubMed ID: 15488564
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic imaging with positron-emission tomography in the advanced-stage ovarian cancers].
Grahek D; Hassan-Sebbag N
Bull Cancer; 2009 Dec; 96(12):1163-71. PubMed ID: 19948451
[TBL] [Abstract][Full Text] [Related]
15. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
16. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
17. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of abdominal computerized tomography. After-care of gynecologic malignancies].
Stummvoll W; Holböck E; Schoissengeier A
Gynakol Geburtshilfliche Rundsch; 1994; 34(1):55-7. PubMed ID: 8019176
[No Abstract] [Full Text] [Related]
19. [FDG-PET and endometrial cancer].
Kolesnikov-Gauthier H; Carpentier P
Bull Cancer; 2012 Jan; 99(1):21-8. PubMed ID: 22182739
[TBL] [Abstract][Full Text] [Related]
20. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
Lai CH; Huang KG; See LC; Yen TC; Tsai CS; Chang TC; Chou HH; Ng KK; Hsueh S; Hong JH
Cancer; 2004 Feb; 100(3):544-52. PubMed ID: 14745871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
